Literature DB >> 35319228

GATA3 Inhibits Viral Infection by Promoting MicroRNA-155 Expression.

Jiaxin Li1,2, Areayi Haiyilati1,2, Linyi Zhou1,2, Juncheng Chen1,2, Yongqiang Wang1,2, Li Gao1,2, Hong Cao1,2, Xiaoqi Li1,2, Shijun J Zheng1,2.   

Abstract

Recognition of viral RNAs by melanoma differentiation associated gene-5 (MDA5) initiates chicken antiviral response by producing type I interferons. Our previous studies showed that chicken microRNA-155-5p (gga-miR-155-5p) enhanced IFN-β expression and suppressed the replication of infectious burse disease virus (IBDV), a double-stranded RNA (dsRNA) virus causing infectious burse disease in chickens. However, the mechanism underlying IBDV-induced gga-miR-155-5p expression in host cells remains elusive. Here, we show that IBDV infection or poly(I:C) treatment of DF-1 cells markedly increased the expression of GATA-binding protein 3 (GATA3), a master regulator for TH2 cell differentiation, and that GATA3 promoted gga-miR-155-5p expression in IBDV-infected or poly(I:C)-treated cells by directly binding to its promoter. Surprisingly, ectopic expression of GATA3 significantly reduced IBDV replication in DF-1 cells, and this reduction could be completely abolished by treatment with gga-miR-155-5p inhibitors, whereas knockdown of GATA3 by RNA interference enhanced IBDV growth, and this enhancement could be blocked with gga-miR-155-5p mimics, indicating that GATA3 suppressed IBDV replication by gga-miR-155-5p. Furthermore, our data show that MDA5 is required for GATA3 expression in host cells with poly(I:C) treatment, so are the adaptor protein TBK1 and transcription factor IRF7, suggesting that induction of GATA3 expression in IBDV-infected cells relies on MDA5-TBK1-IRF7 signaling pathway. These results uncover a novel role for GATA3 as an antivirus transcription factor in innate immune response by promoting miR-155 expression, further our understandings of host response against pathogenic infection, and provide valuable clues to the development of antiviral reagents for public health. IMPORTANCE Gga-miR-155-5p acts as an important antivirus factor against IBDV infection, which causes a severe immunosuppressive disease in chicken. Elucidation of the mechanism regulating gga-miR-155-5p expression in IBDV-infected cells is essential to our understandings of the host response against pathogenic infection. This study shows that transcription factor GATA3 initiated gga-miR-155-5p expression in IBDV-infected cells by directly binding to its promoter, suppressing viral replication. Furthermore, induction of GATA3 expression was attributable to the recognition of dsRNA by MDA5, which initiates signal transduction via TBK1 and IRF7. Thus, it is clear that IBDV induces GATA3 expression via MDA5-TBK1-IRF7 signaling pathway, thereby suppressing IBDV replication by GATA3-mediated gga-miR-155-5p expression. This information remarkably expands our knowledge of the roles for GATA3 as an antivirus transcription factor in host innate immune response particularly at an RNA level and may prove valuable in the development of antiviral drugs for public health.

Entities:  

Keywords:  GATA3; IBDV infection; miR-155

Mesh:

Substances:

Year:  2022        PMID: 35319228      PMCID: PMC9006930          DOI: 10.1128/jvi.01888-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   6.549


  65 in total

Review 1.  The Significance and Therapeutic Potential of GATA3 Expression and Mutation in Breast Cancer: A Systematic Review.

Authors:  Feng Du; Peng Yuan; Teng Wang; Jiuda Zhao; Zitong Zhao; Yang Luo; Binghe Xu
Journal:  Med Res Rev       Date:  2015-08-27       Impact factor: 12.944

2.  gga-miR-9* inhibits IFN production in antiviral innate immunity by targeting interferon regulatory factor 2 to promote IBDV replication.

Authors:  Wei Ouyang; Yong-shan Wang; Xi-ning Du; Hua-jie Liu; Hai-bin Zhang
Journal:  Vet Microbiol       Date:  2015-05-01       Impact factor: 3.293

3.  MicroRNA-155 is a critical regulator of type 2 innate lymphoid cells and IL-33 signaling in experimental models of allergic airway inflammation.

Authors:  Kristina Johansson; Carina Malmhäll; Patricia Ramos-Ramírez; Madeleine Rådinger
Journal:  J Allergy Clin Immunol       Date:  2016-08-01       Impact factor: 10.793

4.  Accumulation of miR-155 and BIC RNA in human B cell lymphomas.

Authors:  Peggy S Eis; Wayne Tam; Liping Sun; Amy Chadburn; Zongdong Li; Mario F Gomez; Elsebet Lund; James E Dahlberg
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-28       Impact factor: 11.205

5.  Regulatory mechanism of microRNA-155 in chicken embryo fibroblasts in response to reticuloendotheliosis virus infection.

Authors:  Chang Gao; Shengyuan Dang; Jie Zhai; Shimin Zheng
Journal:  Vet Microbiol       Date:  2020-02-10       Impact factor: 3.293

Review 6.  Advances in vaccine research against economically important viral diseases of food animals: Infectious bursal disease virus.

Authors:  Daral J Jackwood
Journal:  Vet Microbiol       Date:  2016-11-22       Impact factor: 3.293

7.  gga-miR-454 suppresses infectious bursal disease virus (IBDV) replication via directly targeting IBDV genomic segment B and cellular Suppressors of Cytokine Signaling 6 (SOCS6).

Authors:  Mengjiao Fu; Bin Wang; Xiang Chen; Zhiyuan He; Yongqiang Wang; Xiaoqi Li; Hong Cao; Shijun J Zheng
Journal:  Virus Res       Date:  2018-05-16       Impact factor: 3.303

8.  Suppression of GATA-3 nuclear import and phosphorylation: a novel mechanism of corticosteroid action in allergic disease.

Authors:  Kittipong Maneechotesuwan; Xin Yao; Kazuhiro Ito; Elen Jazrawi; Omar S Usmani; Ian M Adcock; Peter J Barnes
Journal:  PLoS Med       Date:  2009-05-19       Impact factor: 11.069

9.  Enhancer Control of MicroRNA miR-155 Expression in Epstein-Barr Virus-Infected B Cells.

Authors:  C David Wood; Thomas Carvell; Andrea Gunnell; Opeoluwa O Ojeniyi; Cameron Osborne; Michelle J West
Journal:  J Virol       Date:  2018-09-12       Impact factor: 5.103

Review 10.  Comparative Structure and Function Analysis of the RIG-I-Like Receptors: RIG-I and MDA5.

Authors:  Morgan Brisse; Hinh Ly
Journal:  Front Immunol       Date:  2019-07-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.